| SpectraBase Spectrum ID |
8HPlHyrkhg8 |
| Name |
1-(3-Bromobenzyl)-4-(3,4-methylenedioxybenzyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
388.078640922 u |
| Formula |
C19H21BrN2O2 |
| InChI |
InChI=1S/C19H21BrN2O2/c20-17-3-1-2-15(10-17)12-21-6-8-22(9-7-21)13-16-4-5-18-19(11-16)24-14-23-18/h1-5,10-11H,6-9,12-14H2 |
| InChIKey |
FWHZWFWNHHDUKB-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
389.293 g/mol |
| Nominal Mass |
388 u |
| Quality |
948 |
| Retention Index |
2850 |
| SMILES |
C=12C(=CC(CN3CCN(CC=4C=C(C=CC4)Br)CC3)=CC1)OCO2 |
| SPLASH |
splash10-0n99-4950000000-a37083c4eafd6d2f1c3b |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(3-bromobenzyl)-4-(3,4-methylenedioxybenzyl)
1-(1,3-benzodioxol-5-ylmethyl)-4-(3-bromobenzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011238 |
